VFS
MED icon

VSR Financial Services’s Medifast MED Stock Holding History

VSR Financial Services’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,618
Closed -$214K – 606
2015
Q2 		$214K Buy
+6,618
New +$210K 0.02% 515

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VSR Financial Services's MED Position: Q3 2015 in Review

VSR Financial Services sold out of Medifast (MED) in Q3 2015, closing a stake of 6,618 shares — an estimated $214K sold.

VSR Financial Services first reported a position in MED in Q2 2015 and held it in 1 quarter. The position peaked at $214K in Q2 2015. 125 funds tracked by Wall St. Rank hold MED as of Q3 2015.

  • VSR Financial Services reported no remaining Medifast position as of Q3 2015 after selling out during the quarter.
  • VSR Financial Services sold 6,618 Medifast shares in Q3 2015, an estimated $214K.
  • VSR Financial Services first reported a position in Medifast in Q2 2015 and held it in 1 quarter.
  • VSR Financial Services's Medifast position peaked at $214K in Q2 2015.
  • 125 funds tracked by Wall St. Rank held Medifast as of Q3 2015.

Based on VSR Financial Services's 13F filing for Q3 2015, filed 26 Oct 2015.